Nanocomposite-based electrochemical biosensors are revolutionizing lung cancer diagnosis by enabling non-invasive, rapid, and ultrasensitive quantification of protein and genetic biomarkers like CEA, NSE, and AFP from liquid biopsies. This evidence concerns the gene CEACAM5 and lung carcinoma.